Bromazepam (marketed under several brand names, including Lectopam, Lexotan, Lexilium, Lexaurin, Brazepam, Rekotnil, Bromaze and Lexotanil) is a benzodiazepine derivative drug, patented by Roche in 1963 and developed clinically in the 1970s. It has mainly anxiolytic properties and at higher doses also sedative, hypnotic and skeletal muscle relaxant properties.
Read more about Bromazepam: Indications, Side-effects, Tolerance, Dependence and Withdrawal, Contraindications and Special Precautions, Interactions, Pharmacology, Pharmacokinetics, Overdose, Drug Misuse, Legal Status